[
  {
    "ts": null,
    "headline": "Sector Update: Health Care Stocks Rise in Afternoon Trading",
    "summary": "Health care stocks rose Monday afternoon, with the NYSE Health Care Index up 0.9% and the State Stre",
    "url": "https://finnhub.io/api/news?id=eca092d38c287a167bc540bb783de95309fddf0ef7a96d32422f35b12997e486",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765824462,
      "headline": "Sector Update: Health Care Stocks Rise in Afternoon Trading",
      "id": 137795308,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Health care stocks rose Monday afternoon, with the NYSE Health Care Index up 0.9% and the State Stre",
      "url": "https://finnhub.io/api/news?id=eca092d38c287a167bc540bb783de95309fddf0ef7a96d32422f35b12997e486"
    }
  },
  {
    "ts": null,
    "headline": "CHMP Backs Higher-Dose Wegovy as Novo Nordisk Seeks 2026 EU Approval",
    "summary": "NVO gains CHMP backing for a higher-dose Wegovy, paving the way for potential EU approval in 2026 as study data show stronger weight loss.",
    "url": "https://finnhub.io/api/news?id=2c0d915310baacdd85e03645a2003a91a2a333c563e4581a38131a1e543467f2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765812720,
      "headline": "CHMP Backs Higher-Dose Wegovy as Novo Nordisk Seeks 2026 EU Approval",
      "id": 137795309,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "NVO gains CHMP backing for a higher-dose Wegovy, paving the way for potential EU approval in 2026 as study data show stronger weight loss.",
      "url": "https://finnhub.io/api/news?id=2c0d915310baacdd85e03645a2003a91a2a333c563e4581a38131a1e543467f2"
    }
  },
  {
    "ts": null,
    "headline": "Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio",
    "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
    "url": "https://finnhub.io/api/news?id=bc10d4ab2bd72b5db2d8151a28813420dba6df032ac6263782d0f63b30aba0bf",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765810203,
      "headline": "Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio",
      "id": 137795310,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.",
      "url": "https://finnhub.io/api/news?id=bc10d4ab2bd72b5db2d8151a28813420dba6df032ac6263782d0f63b30aba0bf"
    }
  },
  {
    "ts": null,
    "headline": "Update: Market Chatter: Eli Lilly Could Get FDA Decision for Weight-Loss Pill Orforglipron by March 2026",
    "summary": "(Updates with Novo Nordisk's response in the fifth paragraph.) Eli Lilly's (LLY) experimental we",
    "url": "https://finnhub.io/api/news?id=ab90d7a501dcbe533b2ca7ed889bb11e22614c523d8b9fe7b32f15d859a42810",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765799267,
      "headline": "Update: Market Chatter: Eli Lilly Could Get FDA Decision for Weight-Loss Pill Orforglipron by March 2026",
      "id": 137792088,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "(Updates with Novo Nordisk's response in the fifth paragraph.) Eli Lilly's (LLY) experimental we",
      "url": "https://finnhub.io/api/news?id=ab90d7a501dcbe533b2ca7ed889bb11e22614c523d8b9fe7b32f15d859a42810"
    }
  },
  {
    "ts": null,
    "headline": "Amphastar Announces FDA Approval for Teriparatide Injection",
    "summary": "RANCHO CUCAMONGA, CA / ACCESS Newswire / December 15, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration (\"FDA\") has approved the Company's Abbreviated New Drug Application (\"ANDA\") for teriparatide ...",
    "url": "https://finnhub.io/api/news?id=01ca1bdf2635123d7189f3130a05b2d46a7df0dd97b8e66806a7f1c56d2ca8d2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765796400,
      "headline": "Amphastar Announces FDA Approval for Teriparatide Injection",
      "id": 137792089,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "RANCHO CUCAMONGA, CA / ACCESS Newswire / December 15, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the U.S. Food and Drug Administration (\"FDA\") has approved the Company's Abbreviated New Drug Application (\"ANDA\") for teriparatide ...",
      "url": "https://finnhub.io/api/news?id=01ca1bdf2635123d7189f3130a05b2d46a7df0dd97b8e66806a7f1c56d2ca8d2"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly Just Delivered Fantastic News to Investors",
    "summary": "Eli Lilly shares have climbed in the double digits this year.",
    "url": "https://finnhub.io/api/news?id=de186f481848cedb944c7ea494800224d7dd14de8e59faca039381d9d32b556f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765791000,
      "headline": "Eli Lilly Just Delivered Fantastic News to Investors",
      "id": 137792090,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Eli Lilly shares have climbed in the double digits this year.",
      "url": "https://finnhub.io/api/news?id=de186f481848cedb944c7ea494800224d7dd14de8e59faca039381d9d32b556f"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly: Short-Term Upside Exhausted (Rating Downgrade)",
    "summary": "Discover why Eli Lilly's stock downturn may present new opportunities. Learn about valuation, Zepbound pricing, and 2026 prospects.",
    "url": "https://finnhub.io/api/news?id=448ba6fc4320c51b665b8b715f26293581bb59139c3d60125e767fcf45059b36",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765773119,
      "headline": "Eli Lilly: Short-Term Upside Exhausted (Rating Downgrade)",
      "id": 137790106,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1284860965/image_1284860965.jpg?io=getty-c-w1536",
      "related": "LLY",
      "source": "SeekingAlpha",
      "summary": "Discover why Eli Lilly's stock downturn may present new opportunities. Learn about valuation, Zepbound pricing, and 2026 prospects.",
      "url": "https://finnhub.io/api/news?id=448ba6fc4320c51b665b8b715f26293581bb59139c3d60125e767fcf45059b36"
    }
  },
  {
    "ts": null,
    "headline": "Dow Jones Futures Rise; Will AI Rebound Or Drag Down Market? Tesla, Eli Lilly In Buy Areas",
    "summary": "Bears mauled AI stocks, but the Dow Jones and Russell 2000 hit new highs last week. Tesla and Eli Lilly are in buy zones.",
    "url": "https://finnhub.io/api/news?id=d496d74854a608899b599a3891c792fc25995adf5353dc6774eea3beb6f8e7ce",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765770939,
      "headline": "Dow Jones Futures Rise; Will AI Rebound Or Drag Down Market? Tesla, Eli Lilly In Buy Areas",
      "id": 137791988,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "LLY",
      "source": "Yahoo",
      "summary": "Bears mauled AI stocks, but the Dow Jones and Russell 2000 hit new highs last week. Tesla and Eli Lilly are in buy zones.",
      "url": "https://finnhub.io/api/news?id=d496d74854a608899b599a3891c792fc25995adf5353dc6774eea3beb6f8e7ce"
    }
  }
]